Sale!

Cytochrome P450 2C19 Genotyping CYP2C19 Clopidogrel Resistance Test

Original price was: $200.Current price is: $150.

-25%

The Cytochrome P450 2C19 Genotyping CYP2C19 Clopidogrel Resistance Test is a cutting-edge genetic analysis that evaluates how your body processes clopidogrel, a common antiplatelet medication. This test identifies specific genetic variations (*2, *3, *4, *10) in the CYP2C19 gene that can affect drug metabolism and treatment effectiveness. Patients with certain genetic profiles may experience reduced clopidogrel activation, leading to potential treatment resistance and increased cardiovascular risk. The test provides crucial information for personalized medication dosing and alternative treatment options. Using peripheral blood samples and Sanger sequencing technology, this comprehensive analysis delivers results within 7 days. Available for $150 USD, this test helps optimize cardiovascular treatment strategies and improve patient outcomes through genetic-guided therapy.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Cytochrome P450 2C19 Genotyping CYP2C19 Clopidogrel Resistance Test

Understanding Your Genetic Response to Clopidogrel Medication

The Cytochrome P450 2C19 Genotyping CYP2C19 Clopidogrel Resistance Test represents a breakthrough in personalized cardiovascular medicine. This advanced genetic analysis examines how your body processes clopidogrel, a widely prescribed antiplatelet medication used to prevent blood clots in patients with heart conditions, stroke history, or peripheral artery disease. Understanding your genetic profile can significantly impact treatment effectiveness and cardiovascular outcomes.

What This Test Measures and Detects

Our comprehensive genetic analysis focuses on the CYP2C19 gene, specifically targeting four critical genetic variations:

  • CYP2C19*2 variant: The most common loss-of-function allele affecting clopidogrel metabolism
  • CYP2C19*3 variant: Another significant loss-of-function mutation
  • CYP2C19*4 variant: Additional genetic variation impacting drug activation
  • CYP2C19*10 variant: Genetic marker influencing medication response

These genetic variations determine whether you are an extensive metabolizer, intermediate metabolizer, poor metabolizer, or ultra-rapid metabolizer of clopidogrel. Each metabolic profile carries different implications for treatment effectiveness and cardiovascular risk management.

Who Should Consider This Genetic Test

This test is particularly important for individuals in the following situations:

  • Patients prescribed clopidogrel for cardiovascular conditions
  • Individuals with a history of stent thrombosis or recurrent cardiovascular events
  • Patients undergoing coronary artery stenting procedures
  • Those with family history of poor response to antiplatelet medications
  • Individuals experiencing breakthrough cardiovascular events while on clopidogrel therapy
  • Patients considering long-term antiplatelet therapy
  • Those with unexplained treatment resistance to standard medication regimens

Significant Benefits of Genetic Testing

Undergoing CYP2C19 genotyping provides numerous advantages for your cardiovascular health:

  • Personalized Treatment Planning: Tailor medication choices based on your genetic profile
  • Reduced Cardiovascular Risk: Optimize antiplatelet therapy to prevent future events
  • Improved Medication Safety: Avoid ineffective treatments and potential complications
  • Enhanced Treatment Efficacy: Ensure you receive the most appropriate antiplatelet therapy
  • Informed Medical Decisions: Empower yourself and your healthcare provider with genetic insights
  • Cost-Effective Healthcare: Prevent unnecessary medication trials and complications

Understanding Your Test Results

Your genetic test results will categorize you into one of four metabolic phenotypes:

  • Extensive Metabolizer: Normal clopidogrel metabolism – standard dosing typically effective
  • Intermediate Metabolizer: Reduced metabolic activity – may require alternative dosing or monitoring
  • Poor Metabolizer: Significantly impaired metabolism – high risk of treatment failure, alternative medications recommended
  • Ultra-Rapid Metabolizer: Enhanced metabolic activity – may require different therapeutic approaches

It’s crucial to discuss your results with your healthcare provider to determine the most appropriate treatment strategy based on your genetic profile and clinical situation.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $150
Regular Price $200

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Take Control of Your Cardiovascular Health

Don’t leave your medication response to chance. Understanding your genetic profile can make a significant difference in your cardiovascular treatment outcomes. Our advanced Sanger sequencing technology provides accurate, reliable results within 7 days, giving you and your healthcare provider the information needed to make informed treatment decisions.

Ready to optimize your cardiovascular treatment? Book your Cytochrome P450 2C19 Genotyping test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Take the first step toward personalized, effective cardiovascular care.

Note: This test requires a doctor’s prescription for most cases. Prescription requirements do not apply for surgical preparation, pregnancy-related testing, or international travel documentation purposes.